Deals Rumor Mill: Bristol-Myers Squibb, Aramco, Abraaj

By Adam Rhodes (July 5, 2018, 7:12 PM EDT) -- Bristol-Myers Squibb tapped Deutsche Bank and Jefferies to help it sell off its French over-the-counter drugs unit, Reuters reported on Thursday. Citing anonymous sources, the outlet reported that the unit could come with an up to €1.5 billion ($1.75 billion) price tag. Expected suitors include fellow drugmakers Mylan, Procter & Gamble and potentially Recordati, Reuters reported. According to the report, European companies backed by private equity firms are also expected to lob bids for the business....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!